Efficacy of Lu 31-130 in Patients With Schizophrenia

NCT00768326 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Zicronapine
DRUG: Zicronapine
DRUG: Zicronapine
DRUG: Zicronapine
DRUG: Zicronapine
DRUG: Placebo

Sponsor

H. Lundbeck A/S